Published Data Registry

show all
TitleAuthorsJournalPublication year
DOI
PMID
Twin study dissects CXCR3(+) memory B cells as non-heritable feature in multiple sclerosis.(Open Access) Ingelfinger F, Kuiper KL, (...), Becher BMed (New York, N.Y.)2024
Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago.Jacob M, Brugger M, (...), Brunet TNeuropediatrics2024
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria.(Open Access) Wilkens I, Heine J, (...), Hopfner FMovement disorders : official journal of the Movement Disorder Society2024
A Short Progressive Supranuclear Palsy Quality of Life Scale.(Open Access) Wilkens I, Stiel S, (...), Klietz MMovement disorders : official journal of the Movement Disorder Society2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.(Open Access) Joseph-Mathurin N, Feldman RL, (...), Benzinger TLSAlzheimer's & dementia : the journal of the Alzheimer's Association2024
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [(18)F]FET PET, and TSPO PET.(Open Access) Kaiser L, Quach S, (...), Albert NLEuropean journal of nuclear medicine and molecular imaging2024
Virtual reality-empowered deep-learning analysis of brain cells.(Open Access) Kaltenecker D, Al-Maskari R, (...), Ertürk ANature methods2024
Regulated Proteolysis Induces Aberrant Phase Transition of Biomolecular Condensates into Aggregates: A Protective Role for the Chaperone Clusterin.(Open Access) Kamps J, Yuste-Checa P, (...), Tatzelt JJournal of molecular biology2024
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.(Open Access) Karaa A, Bertini E, (...), Mancuso MOrphanet journal of rare diseases2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).(Open Access) Katzdobler S, Nübling G, (...), Levin JJournal of neurology2024